Page 1 of Clinical Trials for human subjects, 47488 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Active, not recruiting
Effect of Liraglutide on Body Weight in Non-diabetic Obese Subjects or Overweight Subjects With Co-morbidities: SCALE™ - Obesity and Pre-diabetes
Last Updated: May 21, 2012
Condition(s): Obesity
2
Completed
Effects of LMWH in Healthy Subjects Treated With TB-402 and Effects of TB-402 in Healthy Subjects Treated With Warfarin
Last Updated: November 17, 2008
Condition(s): Healthy
3
Completed
GSK1349572 Hepatic Impairment Study
Last Updated: July 26, 2011
Condition(s): Healthy Subjects; Hepatic Impairment; Infection, Human Immunodeficiency Virus
4
Recruiting
Study to Assess the Pharmacokinetics of Cabozantinib (XL184) in Hepatic Impaired Adult Subjects
Last Updated: May 24, 2012
Condition(s): Healthy; Hepatic Impairment
5
Active, not recruiting
Evaluation of Antibody Persistence & Immune Memory in Subjects Vaccinated During Adolescence With Twinrix™
Last Updated: November 17, 2011
Condition(s): Hepatitis B; Hepatitis A
6
Completed
Pilot Trial in Sleep Laboratory Setting to Compare the Physiology of Night Time Bladder Function in Subjects With Overactive Bladder (OAB) Versus Subjects That Have Insomnia and Healthy Normal Subjects
Last Updated: March 3, 2011
Condition(s): Bladder Function
7
Completed
Retrospective & Prospective Observational Study of Subjects With ITP
Last Updated: April 23, 2010
Condition(s): Idiopathic Thrombocytopenic Purpura; Thrombocytopenia; Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP); Thrombocytopenic Purpura
8
Recruiting
Efficacy of a 12-week Regimen of Telaprevir, Peginterferon, and Ribavirin in Subjects With Interleukin-28B (IL28B) CC Genotype in Treatment-naive and Prior Relapser Subjects
Last Updated: May 18, 2012
Condition(s): Hepatitis C, Chronic
9
Terminated
Evaluation of [123I] AV94 and SPECT in Subjects With Alzheimer Disease in Comparison to Healthy Subjects
Last Updated: October 5, 2010
Condition(s): Alzheimer Disease
10
Completed
Safety Study of AMG 157 in Healthy Subjects and Subjects With Atopic Dermatitis
Last Updated: May 19, 2011
Condition(s): Atopic Dermatitis; Healthy Volunteers
11
Withdrawn
A Study of GSK2110183 in Subjects With Proteasome Inhibitor Refractory Multiple Myeloma
Last Updated: March 22, 2012
Condition(s): Cancer
12
Recruiting
Study to Assess the Safety and PK of GSK573719 and GSK573719/GW642444(VI) Combination in Healthy Subjects and Subjects With Severe Renal Impairment
Last Updated: April 26, 2012
Condition(s): Pulmonary Disease, Chronic Obstructive
13
Completed
Evaluation of Pharmacokinetics, Safety, And Tolerability Of PF-04971729 In Japanese And Western Healthy Subjects
Last Updated: April 1, 2011
Condition(s): Diabetes Mellitus, Type 2
14
Completed
A Study To Assess the Immune Response Following Administration Of Influenza and Pneumococcal Vaccines To Subjects With Rheumatoid Arthritis Receiving CP-690,550 Or Placebo
Last Updated: March 23, 2012
Condition(s): Rheumatoid Arthritis
15
Recruiting
Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.
Last Updated: May 17, 2012
Condition(s): Ulcerative Colitis; Crohn's Disease
16
Recruiting
Open-label Study of TH-302 as Monotherapy and in Combination With Bortezomib in Subjects With Relapsed/Refractory Multiple Myeloma
Last Updated: April 16, 2012
Condition(s): Multiple Myeloma
17
Recruiting
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis
Last Updated: May 18, 2012
Condition(s): Ulcerative Colitis
18
Completed
A First-time-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ascending Doses of GSK189075A in Healthy Subjects and in Subjects With Type 2 Diabetes Mellitus
Last Updated: April 3, 2012
Condition(s): Diabetes Mellitus, Type 2
19
Completed
A Study of the Pharmacokinetics of Albiglutide in Normal and Renally Impaired Subjects.
Last Updated: January 26, 2012
Condition(s): Renal Impairment; Diabetes Mellitus, Type 2
20
Terminated
Study Evaluating Safety and Efficacy of Tigecycline Versus Imipenem/Cilastatin Subjects With Hospital-Acquired Pneumonia
Last Updated: September 8, 2011
Condition(s): Pneumonia, Bacterial

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=human+subjects

Page 1 of Clinical Trials for human subjects, 47488 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About